Ligand validation:5QCY

E5P: (9R,11S)-11-[(1R)-1-hydroxy-2-({[3-(propan-2-yl)phenyl]methyl}amino)ethyl]-9-methyl-16-(1,3-oxazol-2-yl)-3-[(1R)-1-phenylethyl]-3,12-diazabicyclo[12.3.1]octadeca-1(18),14,16-triene-2,13-dione

E5P is a Ligand Of Interest in 5QCY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5QCY_E5P_A_401	55%	53%	0.137	0.906	0.74	1.07	1	4	0	0	100%	0.9792
5QCY_E5P_C_401	44%	55%	0.158	0.884	0.76	0.95	1	3	0	0	100%	0.9792
5QCY_E5P_B_401	43%	57%	0.169	0.891	0.62	1.03	1	5	0	0	100%	0.9792

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.